Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Aug 8;13:881722. doi: 10.3389/fimmu.2022.881722

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Chen, He, Chen, Wang, Dai, Liang, Wu, Luo, Zhang, Peng, Zhang, Liu, Zhang, Zhang and Cheng

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

PDIA5 exhibits predictive value in immunotherapy response. (A) The PDIA5’s predictive power of response outcomes and overall survival (OS) in human immunotherapy cohorts. (B) The predictive value of PDIA5 in murine immunotherapy cohorts. (C) The expression levels of PDIA5 across cell lines between pre-and post-cytokine-treated groups. *p < 0.05, **p < 0.01, and ***p < 0.001 compared with the Baseline group. (D) The expression level of PDIA5 in different datasets. (E) The predictive value of PDIA5 in response to therapy in BRCA and GBM. RFS, relapse-free survival; OS, overall survival.